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Introduction
The timely and sustained delivery of
effective health interventions to communi-
ties in developing countries is one of the
greatest challenges in global health. Mil-
lions of the world’s poorest citizens
continue to be afflicted by bacterial, viral,
and parasitic infections that have persisted,
mainly in the tropics—the so-called ne-
glected tropical diseases (NTDs)—despite
the availability of safe and cost-effective
interventions for the control and elimina-
tion of many of these diseases. Access to
these interventions (or control tools) re-
mains low and inadequate, particularly in
sub-Saharan Africa [1,2]. The NTDs,
including onchocerciasis, schistosomiasis,
lymphatic filariasis, trachoma, and soil-
transmitted helminthiasis, have been
shown to affect the poorest of the poor
disproportionately. Addressing the NTDs,
therefore, will be an essential element in
poverty alleviation programs [3,4].
A number of important international
single-disease control partnerships have
been developed over the last few decades
[5–7]. To date, however, there has been
little integration among these partnerships
[3]. Integration refers to the creation of
linkages among existing programs to im-
prove the delivery of health interventions
given existing commitments and resources.
The presence of many common elements
and general arguments about economies of
scale provide strong reasons to believe that
integration amongst partnerships can help
improve both efficiency and effectiveness.
Interest in integration is currently at an
all-time high, due in part to new funding
for integration (the Bill & Melinda Gates
Foundation has announced research
grants to investigate integration of NTDs,
and the United States Agency for Inter-
national Development [USAID] has
awarded operational grants to scale-up
integrated NTD control programs), the
creation of the Global Network for
Neglected Tropical Diseases Control
(GNNTDC; http://gnntdc.sabin.org/),
and high-level political commitment to
address these scourges [8]. In addition,
reports of successful national control pro-
grams for single diseases supported by these
partnerships (such as trachoma control in
Morocco and lymphatic filariasis control in
Egypt) bolster the case that integration be
prioritized in affected countries.
While there has been significant discus-
sion about the integration of single-disease
partnerships [9–11] and the potential
usefulness of such approaches in helping
to tackle the burden of NTDs, there is
limited experience in implementing integra-
tion and even less experience in conducting
systematic analysis of these experiences.
Recently, a number of articles have dis-
cussed potential challenges and opportuni-
ties, and have estimated potential benefits,
including cost savings [12–14].
The lack of a common understanding of
integration for disease control programs
may be a significant impediment towards
implementing integration, despite signifi-
cant interest in the topic. This article
presents a conceptual framework to help
guide the discussion about integration of
NTD control partnerships. It then pro-
vides specific examples of potential oppor-
tunities and actual cases of integration of
NTDs, and places these examples within
the conceptual framework. The main
purpose of this article is to provide a tool
for thinking about integration—to aid the
development, implementation, and evalu-
ation of future efforts at integrating NTD
control programs. This framework could
also be used for assessing other forms of
integration among service-oriented pro-
grams. This article does not provide
lessons from ongoing NTD integration
efforts, because the existing attempts are at
too early a stage to generate results.
Conceptualizing Integration
Integration has been interpreted to
mean different things to different organi-
zations and individuals. In fact, many
different options exist for integration. To
understand the differences among these
options, it is important to define with some
precision the dimensions along which
integration can occur. The following
framework can be used to conceptualize
the options based on differences in do-
main, level, and degree of integration.
Domain: What Is Being Integrated?
Building upon the framework for inte-
gration of human services developed by
Agranoff and Pattakos, integration can
occur within a number of different do-
mains [15]. Distinguishing among these
different domains helps to answer the
question, what is being integrated? The
following provides a description of each
domain using health examples:
N Activity domain: Joining core activ-
ities of separate programs. Activity
integration could involve joint distri-
butions, multi-disease evaluations, or
joint training sessions for community
distributors.
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functions of separate programs, such as
advocacy, needs and priority assess-
ment, technical and financial guideline
development, and programming and
coordination activities. Policy integra-
tion could include the development of
multi-disease indicators and harmo-
nized incentive structures for commu-
nity distributors.
N Organizationalstructuredomain:
Merging separate programs into a
common structure or forming a new
organization. Organizational integra-
tion could involve the formation of a
new partnership for community-based
distribution or the consolidation of one
diseaseprograminto anotherwhereone
disease program has clear comparative
advantages over another.
Level: Where Is Integration
Occurring?
Integration can occur at different levels
in a health system. The costs and benefits
of integration will vary depending on the
particular level targeted for integration.
Distinguishing among the levels helps to
answer the question, where is integration
occurring? It is important to note that while
integration can occur at any of these levels,
integration at one level will likely have
implications at other levels. The following
provides an overview of three levels and
examples of integration that could occur at
each level:
N Global: Integration among the inter-
national partnerships and other inter-
national health organizations involved
in the financing, planning, and imple-
menting of disease-specific programs.
For example, the major public–private
partnerships could work collaborative-
ly on the development of joint indica-
tors for multi-disease program evalua-
tions (i.e., in the policy domain).
N National/regional: Integration
among national or regional disease-
specific programs, various divisions
within the Ministry of Health (MoH),
other relevant public sector offices,
non-governmental organizations
(NGOs), and other national or region-
al partners. For example, the national
program coordinators could coordi-
nate their activities at the national
level in order to guide the activities at
the regional, district, and community
levels (i.e., in the activity domain).
N Local (district/village/communi-
ty): Integration among the implemen-
ters, including MoH employees, NGOs,
community volunteers, and relevant
community-based partners. For exam-
ple, districts could consolidate the
various training sessions for community
distributors into a single training session
(i.e., in the activity domain).
Degree: How Is Integration
Occurring?
Finally, for a given domain and level,
the degree to which programs actually
implement integration can also vary.
Distinguishing among these different de-
grees helps answer the question, how is
integration occurring? The following provides
an overview of the different degrees over
which integration could occur:
N Coordination: Communication and
information exchange among distinct
programs for the purpose of simplify-
ing the implementation of the respec-
tive programs. For example, programs
could work together at the national
level to develop an annual plan for
implementation (i.e., in the activity
domain and at the national level).
N Collaboration: Increased coopera-
tion among disease-specific programs,
which, in addition to increased coordi-
nation, could include the sharing of
resources or personnel. For example,
multiple programs can join together to
purchase vehicles and other equipment
that could then be used by all of the
programs (i.e., in the activity domain
and at the national and regional levels).
N Consolidation: Implementation of a
p o r t i o no ra ne n t i r ep r o g r a mb y
another program. Consolidation im-
plies the replacement of either a
portion or the entire program by a
new effort or entity. For example,
instead of conducting multiple single-
disease training sessions for district-
level health workers, regional-level
health workers could instead offer a
single once-a-year training session for
multiple-disease programs (i.e., in the
activity domain and at the implemen-
tation level).
Examples of Integration for
NTD Control Programs
To illustrate the above framework, we
have taken real-world examples of and
potential opportunities for integration in
NTD control programs and have catego-
rized them in Table 1 by level (global,
national/regional, and local) and domain
(activity, policy, and organizational), using
the framework. For each example, the text
in Table 1 describes the degree of
integration.
Global/Activity:
Gates Foundation–funded opera-
tional research projects (collabora-
tion): In the fall of 2006, the Bill &
Melinda Gates Foundation awarded ap-
proximately US$46.7 million in research
grants to multi-disease partnerships to
investigate the costs and benefits of
integrated approaches for NTDs [16].
Multiple organizations are involved in
these grants, including the International
Trachoma Initiative, the Schistosomiasis
Table 1. Examples of Integration for NTD Control Programs, Organized by Level and Domain.
LEVEL
Global National/Regional Local
DOMAIN Activity Gates Foundation–funded operational
research projects (collaboration)
Coordination of treatment distributions
at national level
Joint training sessions for local distributors
(collaboration)
Policy Coordinated guidelines for co-
administration of treatments
APOC technical support to countries
(coordination)
Harmonized incentives for local distributors
(coordination)
Organizational The Global Network for Neglected Tropical
Diseases Control (collaboration)
Multi-disease surveillance (consolidation) Multi-disease drug distributors (consolidation)
Note: The text describing each example indicates the degree of integration (coordination, collaboration, and consolidation).
doi:10.1371/journal.pntd.0000174.t001
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Control and Prevention, Emory Universi-
ty, and the Carter Center. Research for
these projects will take place in numerous
countries and cover numerous diseases.
Additional collaborative efforts include
attempts to standardize costing methodol-
ogies across all of these Gates-funded
projects.
National-Regional/Activity:
Coordination of distributions at
national level (coordination): In many
countries, the timing and sequencing of drug
distributions are coordinated at the national
level and built into joint national operational
plans. By coordinating these distributions at
the national level,resources can be deployed
more efficiently at the national and district
levels towards these programs and addition-
al opportunities for integration can be
identified.
Local/Activity:
Joint training sessions (collabora-
tion): District health centers in certain
communities conduct joint training session
for community distributors and other
health workers. Since many of the training
sessions are similar in nature, training
sessions can be shorter, and health workers
and community distributors need only
travel once to receive their complete
training package.
Global/Policy:
Coordinated guidelines for co-
administration (coordination): The
World Health Organization (WHO) re-
cently completed guidelines for countries
on integrated chemotherapies for helmin-
thic infections [17]. These guidelines
summarize the academic literature of
the safety of such practices and provide
suggested guidelines for the development
of national guidelines for integrated
control.
National-Regional/Policy:
APOC technical support to coun-
tries (coordination): The African Pro-
gramme for Onchocerciasis Control
(APOC) has recently expanded its man-
date to be able to provide assist-
ance to national governments for the
development of national policies on inte-
grated NTD control that include oncho-
cerciasis [18]. APOC is the longest
running single-disease control program
and has developed extensive expertise
and knowledge in all aspects of disease
control. By leveraging their expertise and
contacts, countries may be able to more
quickly develop new integrated disease
control programs.
Local/Policy:
Harmonized incentives (coordina-
tion): A key challenge identified by many
of the single-disease control programs is
the lack of standardized remuneration
packages, which potentially creates harm-
ful incentives for the community distribu-
tors. Villages could establish uniform
compensation guidelines for community
distributors.
Global/Organizational:
GNNTDC (collaboration): In 2006,
the GNNTDC was formed to coordinate
advocacy and information dissemination
efforts for integrated NTD control at the
international level. The goal is to help link
NTD control efforts with those that have
been more broadly aimed at poverty
reduction.
National-Regional/Organizational:
Multi-disease surveillance (con-
solidation): In some countries, a single
coordinator has been put in charge of
national surveillance for multiple diseases.
It may be possible for surveillance officers
to collect samples for more than one
disease during their visits to the infected
areas, thereby saving time and other
resources.
Local/Organizational:
Multi-disease drug distributors
(consolidation): In many villages, the
same individual is made responsible for
the distribution of more than one disease
control program. If the same individual is
made responsible for multi-disease distri-
butions, it could reduce the amount of
time these people need to devote to
notifying their constituents, attending
trainings, and implementing the distribu-
tions. It may also lead to important
productivity gains since there is a learning
curve associated with each of these
programs.
Conclusions
A common understanding of the con-
cept of integration can help guide future
discussions about the opportunities and
challenges for integration among NTD
control programs. The framework pre-
sented in this article provides a tool for
clarifying the different domains, levels, and
degrees of integration. This framework has
already been used in two situations: to
assist in the development of new integra-
tion strategies for APOC, and to guide the
development of strategies to integrate
trachoma and lymphatic filariasis control
programs; in both instances, the frame-
work was helpful.
The integration of NTD control pro-
grams offers the potential for improving
the delivery of NTD control programs in
resource-poor regions such as sub-Saharan
Africa, where millions remain at risk of
these diseases. We have provided some
real-world examples of integrated NTD
control activities and have demonstrated
how these efforts can be categorized using
the framework. There is a need to
accelerate the implementation of integrat-
ed NTD control activities, but they also
must be evaluated in a systematic manner.
We believe this framework can help
understand how to best create linkages
among these programs and how to deliver
much needed services to affected commu-
nities in more efficient and effective ways.
Acknowledgments
The findings and conclusions in this report are
those of the authors and do not necessarily
represent the views of Harvard University or the
Bill & Melinda Gates Foundation.
References
1. Molyneux DH (2004) ‘‘Neglected’’ diseases but
unrecognised successes—challenges and opportu-
nities for infectious disease control. Lancet 364:
380–383.
2. Engels D, Savioli L (2006) Reconsidering the
underestimated burden caused by neglected
tropical diseases. Trends Parasitol 22: 363–366.
3. Molyneux DH, Hotez PJ, Fenwick A (2005)
‘‘Rapid-impact interventions’’: how a policy of
integrated control for Africa’s neglected tropical
diseases could benefit the poor. PLoS Med 2:
e336. doi:10.1371/journal.pmed.0020336.
4. Molyneux DH, Nantulya VM (2004) Linking
disease control programmes in rural Africa: a
pro-poor strategy to reach Abuja targets and
millennium development goals. BMJ 328:
1129–1132.
5. Seketeli A, Adeoye G, Eyamba A, Nnoruka E,
Drameh P, et al. (2002) The achievements and
challenges of the African Programme for Oncho-
cerciasis Control (APOC). Ann Trop Med Para-
sitol 96 (Suppl 1): S15–S28.
6. Molyneux DH, Zagaria N (2002) Lymphatic
filariasis elimination: progress in global pro-
gramme development. Ann Trop Med Parasitol
96 (Suppl 2): S15–S40.
7. Mecaskey JW, Knirsch CA, Kumaresan JA,
Cook JA (2003) The possibility of eliminating
blinding trachoma. Lancet Infect Dis 3: 728–
734.
8. The Lancet (2007) A turning point for neglected
tropical disease control. Lancet 369: 1404.
9. Utzinger J, de Savigny D (2006) Control of
neglected tropical diseases: integrated chemother-
apy and beyond. PLoS Med 3: e112.
doi:10.1371/journal.pmed.0030112.
www.plosntds.org 3 April 2008 | Volume 2 | Issue 4 | e17410. Molyneux DH, Bradley M, Hoerauf A,
Kyelem D, Taylor MJ (2003) Mass drug
treatment for lymphatic filariasis and onchocer-
ciasis. Trends Parasitol 19: 516–522.
11. Utzinger J, Keiser J (2004) Schistosomiasis and
soil-transmitted helminthiasis: common drugs for
treatment and control. Expert Opin Pharmac-
other 5: 263–285.
12. Brady MA, Hooper PJ, Ottesen EA (2006)
Projected benefits from integrating NTD pro-
grams in sub-Saharan Africa. Trends Parasitol
22: 285–291.
13. Lammie PJ, Fenwick A, Utzinger J (2006) A
blueprint for success: integration of neglected
tropical disease control programmes. Trends
Parasitol 22: 313–321.
14. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E,
Ehrlich Sachs S, et al. (2006) Incorporating a
rapid-impact package for neglected tropical
diseases with programs for HIV/AIDS, tubercu-
losis, and malaria. PLoS Med 3: e102.
doi:10.1371/journal.pmed.0030102.
15. Agranoff R, Pattakos A (1979) Dimensions of
services integration: service delivery, program
linkage, policy management, organizational struc-
ture. Rockville (Maryland): Department of Health
Education and Welfare Office of Assistant
Secretary for Planning and Evaluation, Project
Share. pp ix, 187.
16. Bill & Melinda Gates Foundation (2006) Leading
global health organizations receive $46.7 million
from Gates Foundation to integrate programs
fighting neglected tropical diseases [press release].
Available: http://www.gatesfoundation.org/
GlobalHealth/Announcements/Announce-061219.
htm. Accessed 4 April 2008. 19 December.
17. WHO (2006) Preventive chemotherapy in human
helminthiasis: coordinated use of anthelminthic
drugs in control interventions: a manual for
health professionals and programme managers.
Geneva, Switzerland: The World Health Orga-
nization.
18. Hodgkin C, Molyneux DH, Abiose A,
Philippon B, Reich MR, et al. (2007) The future
of onchocerciasis control in Africa. PLoS Negl
Trop Dis 1: e74. doi:10.1371/journal.pntd.
0000074.
www.plosntds.org 4 April 2008 | Volume 2 | Issue 4 | e174